A closed-loop approach to antiretroviral therapies for HIV infection
暂无分享,去创建一个
Carlos E. D'Attellis | Pablo S. Rivadeneira | Vicente Costanza | Federico L. Biafore | C. D'Attellis | V. Costanza | P. Rivadeneira | F. Biafore | P. Rivadeneira
[1] Shuzhi Sam Ge,et al. Nonlinear control of a dynamic model of HIV-1 , 2005, IEEE Transactions on Biomedical Engineering.
[2] Denise E. Kirschner,et al. Using Mathematics to Understand HIV Immune Dynamics , 1997 .
[3] A S Perelson,et al. Modeling plasma virus concentration during primary HIV infection. , 2000, Journal of theoretical biology.
[4] J. Lange,et al. Treatment of HIV Infection , 1996, Drug safety.
[5] J. M. Lemos,et al. NONLINEAR CONTROL OF HIV-1 INFECTION WITH A SINGULAR PERTURBATION MODEL , 2006 .
[6] M. Nowak,et al. Virus dynamics: Mathematical principles of immunology and virology , 2001 .
[7] R M May,et al. AIDS pathogenesis: mathematical models of HIV and SIV infections. , 1992 .
[8] J. J. Henning,et al. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 , 1998, HIV clinical trials.
[9] Shigui Ruan,et al. Mathematical Biology Digital Object Identifier (DOI): , 2000 .
[10] D. Kirschner,et al. Optimal control of the chemotherapy of HIV , 1997, Journal of mathematical biology.
[11] Arthur E. Bryson,et al. Applied Optimal Control , 1969 .
[12] D. Bangsberg,et al. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. , 2004, The Journal of antimicrobial chemotherapy.
[13] Guanrong Chen,et al. Feedback control of a biodynamical model of HIV-1 , 2001, IEEE Transactions on Biomedical Engineering.
[14] Chung Choo Chung,et al. Optimized structured treatment interruption for HIV therapy and its performance analysis on controllability , 2006, 2004 43rd IEEE Conference on Decision and Control (CDC) (IEEE Cat. No.04CH37601).
[15] Alan S. Perelson,et al. Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..
[16] Praphan Phanuphak,et al. Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-infected patients , 2006, AIDS.
[17] F. Menezes Campello de Souza,et al. Modeling the dynamics of HIV-1 and CD4 and CD8 lymphocytes , 1999 .
[18] Eduardo D. Sontag,et al. Mathematical Control Theory Second Edition , 1998 .
[19] A. Perelson,et al. Dynamics of HIV infection of CD4+ T cells. , 1993, Mathematical biosciences.
[20] A. Chervy. Méthodologie de la modélisation illustrée par une analyse critique de plusieurs modèles relatifs à un procédé de production d'antibiotique , 1985 .
[21] Claude H. Moog,et al. Modeling of the HIV/AIDS Infection: An Aid for an Early Diagnosis of Patients , 2007 .
[22] Xiaohua Xia,et al. When to initiate HIV therapy: a control theoretic approach , 2003, IEEE Transactions on Biomedical Engineering.
[23] José Álvarez-Ramírez,et al. Feedback Control of the chemotherapy of HIV , 2000, Int. J. Bifurc. Chaos.
[24] R. Lempicki,et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[25] M A Nowak,et al. Mathematical biology of HIV infections: antigenic variation and diversity threshold. , 1991, Mathematical biosciences.
[26] Eduardo D. Sontag,et al. Mathematical Control Theory: Deterministic Finite Dimensional Systems , 1990 .